Transfer of lipophilic drugs between liposomal membranes and biological interfaces: Consequences for drug delivery

被引:148
作者
Fahr, A
van Hoogevest, P
May, S
Bergstrand, N
Leigh, MLS
机构
[1] Univ Jena, Dept Pharmaceut Technol, D-07743 Jena, Germany
[2] N Dakota State Univ, Dept Phys, Fargo, ND 58105 USA
[3] Phares Drug Delivery AG, CH-4132 Muttenz, Switzerland
[4] Univ Basel, Inst Pharmaceut Technol, Dept Pharmaceut Sci, CH-4056 Basel, Switzerland
基金
美国国家科学基金会;
关键词
lipophilic drugs; phospholipid; liposomes; inter-membrane; transfer kinetics; membrane solubility; pharmacokinetics; bioavailability;
D O I
10.1016/j.ejps.2005.05.012
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
This review paper describes the present knowledge on the interaction of lipophilic, poorly water soluble, drugs with liposomal membranes and the reversibility of this interaction. This interaction is discussed in the context of equilibrium and spontaneous transfer kinetics of the drug, when the liposomes are brought in co-dispersion with other artificial or natural phospholipid membranes in an aqueous medium. The focus is on drugs, which have the potential to partition (dissolve) in a lipid membrane but do not perturb membranes. The degree of interaction is described as solubility of a drug in phospholipid membranes and the kinetics of transfer of a lipophilic drug between membranes. Finally, the consequences of these two factors on the design of lipid based carriers for oral, as well as parenteral use, for lipophilic drugs and lead selection of oral lipophilic drugs is described. Since liposomes serve as model-membranes for natural membranes, the assessment of lipid solubility and transfer kinetics of lipophilic drug using liposome formulations may additionally have predictive value for bioavailability and biodistribution and the pharmacokinetics of lipophilic drugs after parenteral as well as oral administration. (C) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:251 / 265
页数:15
相关论文
共 90 条